Clinical Trial Update: Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of edetate calcium disodium or succimer in patients with acute myeloid leukemia or myelodysplastic syndrome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Blast Phase Chronic Myeloid Leukemia Bcr-abl1-positive
• Chronic Myeloid Leukemia Bcr-abl1 Positive
• Myelodysplastic Myeloproliferative Neoplasm
• Myelodysplastic Syndrome
• Myeloproliferative Neoplasm

Drugs mentioned

• Edetate calcium disodium (calcium disodium edetate)
• Succimer (dimercaptosuccinic acid)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Phase 1 | Status: RECRUITING